Jay Feingold
2021
In 2021, Jay Feingold earned a total compensation of $7.7M as Chief Medical Officer at Pyxis Oncology.
Compensation breakdown
| Non-Equity Incentive Plan | $255,075 |
|---|---|
| Option Awards | $6,603,508 |
| Salary | $151,515 |
| Stock Awards | $700,000 |
| Total | $7,710,098 |
Feingold received $6.6M in option awards, accounting for 86% of the total pay in 2021.
Feingold also received $255.1K in non-equity incentive plan, $151.5K in salary and $700K in stock awards.
Rankings
In 2021, Jay Feingold's compensation ranked 1,515th out of 12,415 executives tracked by ExecPay. In other words, Feingold earned more than 87.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,515 out of 12,415 | 88th |
Division Manufacturing | 549 out of 5,505 | 90th |
Major group Chemicals And Allied Products | 209 out of 2,375 | 91st |
Industry group Drugs | 174 out of 2,096 | 92nd |
Industry Pharmaceutical Preparations | 119 out of 1,546 | 92nd |
Source: SEC filing on April 28, 2022.
Feingold's colleagues
We found two more compensation records of executives who worked with Jay Feingold at Pyxis Oncology in 2021.